G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS
This group comprises gynecological antiinfectives and antiseptics mainly for local use. See also:
J - Antiinfectives for systemic use
D06 - Antibiotics and chemotherapeutics for dermatological use
P01AB - Nitroimidazole derivatives
|The DDDs are based on the treatment of vaginal infections.|
G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS
This group comprises preparations, mainly for local use.
Combinations with corticosteroids, see G01B.
Antivirals for topical use, including gynecological use, such as podophyllotoxin, are classified in D06 - Antibiotics and chemotherapeutics for dermatological use.
Nystatin in combination with nifuratel is classified in G01AA51.
Combinations of different sulfonamides are given the code G01AE10.
G01AF Imidazole derivatives
Imidazole derivatives (e.g. metronidazole and ornidazole) in formulations for vaginal administration are classified in this group. Parenteral formulations are classified in J01XD, as they are mainly used in anaerobic infections. Imidazole derivatives in oral (including tablets used for the treatment of gynecological infections only) and rectal dosage forms are classified in P01AB. Metronidazole for topical use in skin disorders is classified in D06BX - Other chemotherapeutics.
G01AG Triazole derivatives
Fluconazole tablets in single dose packages, only for gynecological infections, are classified together with other packages for systemic use in J02A - Antimycotics for systemic use.
Nifuratel in combination with nystatin is classified in G01AA51.
Last updated: 2016-12-19